Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus
ConditionType 2 Diabetes Mellitus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-69
SponsorCardenal Herrera University
About this trial
This study aims to compare carotid intima-media thickness (CIMT) and layer-specific texture characteristics of the carotid wall between individuals with Type 2 diabetes mellitus (T2DM) and normoglycemic controls, to assess the impact of T2DM on these ultrasound variables and evaluate their ability to discriminate between low and high cardiovascular risk at 10 years.
Eligibility criteria
Qualifiers
European adults.
Age between 40 and 69 years.
Confirmed diagnosis of type 2 diabetes mellitus.
No established cardiovascular disease.
Disqualifiers
History of clinical cardiovascular disease (secondary prevention).
Type 1 diabetes mellitus.
Patients with established severe target organ damage or conditions that automatically classify them as very high cardiovascular risk according to ESC guidelines.
Advanced chronic kidney disease (estimated glomerular filtration rate <30 mL/min/1.73 m²).
Trial design
Treatments tested in this trial
- SCORE2
- SCORE2-Diabetes
- Ultrasound Assessment
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov